Skip to main content
Premium Trial:

Request an Annual Quote

ArcherDx SureShot Triple Fusion-Positive NGS Control

ArcherDx, in partnership with Horizon Discovery Group, has launched the Archer SureShot ALK, RET, ROS1 Fusion Control to benchmark greater in gene fusion detection using Archer FusionPlex Panels. The reference control is composed of formalin-fixed paraffin-embedded curls of homogeneously mixed, precisely defined cell lines that contain EML4-ALK, CCDC6-RET, and SLC34A2-ROS1 fusions. SureShot negative controls are also available, containing 100 percent wild-type cells that carry no target-gene fusion.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more